• Assure Holdings (IOM) has been approved to list its shares on the NASDAQ Capital Market
  • Trading will begin on September 29, 2021, under the ticker symbol IONM
  • The company believes the listing will benefit its liquidity and appeal for potential future acquisitions
  • Assure Holdings provides a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries
  • Assure Holdings (IOM) is unchanged trading at $9.30 per share

Assure Holdings (IOM) has been approved to list its shares on the NASDAQ Capital Market.

Trading will begin on September 29, 2021, under the ticker symbol IONM.

The company’s stock will continue trading on the OTCQB Venture Market until trading commences on the NASDAQ.

It will retain its listing on the TSXV.

John A. Farlinger, Assure’s Executive Chairman and CEO, stated,

“Our listing on NASDAQ represents a significant milestone for Assure. We believe that a NASDAQ listing increases Assure’s visibility in the industry. In addition, the listing is expected to provide increased liquidity to our investors, improve our access to capital and enhance the value of our common stock for future M&A transactions.”

Assure Holdings provides a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings (IOM) is unchanged trading at $9.30 per share as of 11:35 am ET.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.